TAM Receptor
Catalog No. | Inhibitor Name | Mer | Axl | Tyro3 | Other |
---|---|---|---|---|---|
A10996 | Cabozantinib | *** | |||
A10153 | BMS-777607 | ** | **** | **** | VEGFR2/KDR,c-Met,Kit |
A13741 | R428 | ** | RON,Met,FLT3 | ||
A14143 | UNC2250 | **** | * | VEGFR2/KDR,c-Met,Kit | |
A15904 | UNC2025 | **** | ** | ** | |
A15776 | TP-0903 | ** | FLT3 | ||
A15917 | NPS-1034 | *** | |||
A13003 | LDC1267 | *** | * | *** | Met |
A14276 | UNC2881 | **** | * | * |
Notes:
1.Hover mouse over " " to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of " " is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.
-
XL184 free base (Cabozantinib)
Catalog No. A10996 VEGFR 抑制剂XL184 free base (Cabozantinib)是设计用来抑制多种受体酪氨酸激酶(特别是MET和VEGFR2)的小分子。 了解更多 -
BMS-777607
Catalog No. A10153 c-Met 抑制剂BMS-777607是一种MET酪氨酸激酶抑制剂,与c-Met蛋白或HGFR结合,可防止HGF结合并破坏MET信号通路。 了解更多 -
R428
Catalog No. A13741 -
Gilteritinib (ASP2215)
Catalog No. A14411 FLT3/Axl 抑制剂Gilteritinib (ASP2215)是一种有效的FLT3/AXL抑制剂,对具有AML突变或FLT3-ITD和FLT3-D835的AML具有有效的抗白血病活性。 了解更多 -
TP-0903
Catalog No. A15776 -
SGI-7079
Catalog No. A15864 -
Glesatinib hydrochloride
Catalog No. A16257 -
UNC2881
Catalog No. A14276 -
Gilteritinib hemifumarate
Catalog No. A18235 FLT3/AXL inhibitorGilteritinib hemifumarate is a potent FLT3/AXL inhibitor with IC50 of 0.29 nM/0.73 nM, respectively. 了解更多 -
BMS 777607
Catalog No. A21638 c-Met/Axl/Ron/Tyro3 inhibitorBMS 777607 is a Met-related inhibitor for c-Met, Axl, Ron and Tyro3 with IC50s of 3.9 nM, 1.1 nM, 1.8 nM and 4.3 nM, respectively. 了解更多